New evidence highlights the critical role of inflammation in liver cancer prognosis. A recent study in Hepatology International demonstrates how systemic inflammatory response markers significantly improve discrimination in prognostic models for hepatocellular carcinoma (HCC)—enhancing risk stratification and guiding clinical decision-making.

Read the full article here: https://link.springer.com/article/10.1007/s12072-025-10806-6…